Abstract:Tumor necrosis factor α (TNF-α) is a cytokine that plays a major role in several chronic inflammatory disorders. Anti-TNF-α therapy has been widely employed in clinic. However, the source of natural human TNF-α is so limited that it's difficult to meet the research needs. The purpose of this project is to construct an effective prokaryotic expression system for recombinant human TNF α (rhTNF-α). The sequence of hTNF-α is retrieved from Entrez Gene at NCBI. The whole gene of hTNF-α is optimized, synthezied by a company, inserted into the expression vector pET-28a (+) and expressed in E. coli BL21 (DE3). The N-terminus of hTNF-α contains a His-tag and a TEV protease site. The 10 ×His-tag is used to purify the protein by Ni+-NTA, and the TEV protease site is used to remove the His-tag. The soluble expression conditions of hTNF-α were optimized by orthogonal array design. The large-scale fermentation was carried out under optimized conditions. The expressed rhTNF-α protein was purified by Ni+ affinity chromatography. Then, the 10 ×His tag was removed by TEV protease treatment and followed though Ni+ column again. The purification effect was identified by SDS-PAGE and western blot. The biological activity of rhTNF-α was evaluated by MTT method with L929 cells as target cells. The recombinant cloning and expressing plasmid of rhTNF-α was successfully constructed. The outflow from the Ni column was the purified rhTNF-α, showing single polypeptide band by SDS-PAGE. The productivity of purified rhTNF-α is about 4.17 mg/L. L929 cell cytotoxicity assay showed IC50<10 ng/mL. An effective prokaryotic expression system for rhTNF-α was successfully constructed in our study. The application of two-step Ni+ affinity chromatography purification method could produce soluble rhTNF-α protein with high purity and relative bioactivity.

A convenient method for hTfR1 inclusion body purification.

Preparation and Characterization of a Novel Monoclonal Antibody Against the Extracellular Domain of Human Transferrin Receptor.

A Simple Method for Obtaining Transferrins from Human Plasma and Porcine Serum: Preparations and Properties

Expression and Purification of Human CD81 Membrane Protein

Expression, purification, and characterization of recombinant human H-chain ferritin

High Efficient Expression and Purification of the Escherichia Coli T-protein

One-Step On-Column Purification And Refolding Of A Single-Chain Variable Fragment (Scfv) Antibody Against Tumour Necrosis Factor Alpha

Expression, Purification and Transduction Activity Identification of TAT-NEP1-40

Facile Purification of Escherichia Coli Expressed Tag-Free Recombinant Human Tumor Necrosis Factor Alpha from Supernatant

Expression and Purification of Recombinant Human Tumor Necrosis Factor α in Escherichia Coli

Expression and Purification of Human Transforming Growth Factor Β1 in E. Coli RR1

Purification and Characterization of Rgd Tumor-Homing Peptide Conjugated Human Tumor Necrosis Factor Alpha Over-Expressed in Escherichia Coli

Production of Extracellular Domain of Human Tissue Factor Using Maltose-Binding Protein Fusion System.

Preparation and identification of scFv and bsFv against transferrin receptor

One-step refolding and purification of recombinant human tumor necrosis factor-α (rhTNF-α) using ion-exchange chromatography.

Soluble Expression and Purification of Recombinant Bovine Ferritin H-chain.

Clone and expression of human transferrin receptor gene:a marker gene for magnetic resonance imaging

Expression and Purification of Human Tumor Necrosis FactorαFusing with Oligo- Histidine

High Level Expression, Purification and Characterization of Active Fusion Human C1q and Tumor Necrosis Factor Related Protein 2 (hctrp2) in Escherichia Coli

Separation And Purification Of Escherichia Coli-Ex Pressed Human Thymosin-Alpha 1 Using Affinity Chromatography And High-Performance Liquid Chromatography

Cloning and High Expression of Full Length Htrf1 in E. Coli